Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, shared Cancer Network’s post on X:
“Combining ADCs: the future is now.
(Though it will require more payload differentiation…!)”
Quoting Cancer Network’s post:
“Combining ADCs has shown a potential improvement in survival, but it may also come with increased toxicities.”
Read an impactful article about ADCs.